Latest stories on CCCC
C4 Therapeutics Highlights Cemsidomide Strategy and Trial Progress
TipRanks58 · neutralproduct/pr
C4 Therapeutics, Inc. (CCCC) files 8-K
SEC 8-K50 · neutralgeneral
C4 Therapeutics "Buy" On Cemsidomide Advancement And Competitor's Positive Readout
Seeking Alpha61 · neutralanalyst
Bristol-Myers multiple myeloma data boosts C4
Seeking Alpha67 · bullishproduct/pr